Fresenius Brings Antibiotics Row With Cubist To PTAB
Fresenius Kabi USA LLC has taken its fight with Cubist Pharmaceuticals Inc. over a generic version of antibiotic Cubicin to the Patent Trial and Appeal Board, filing petitions for inter partes...To view the full article, register now.
Already a subscriber? Click here to view full article